Clinical Trial Update: Diabetes Prevention Program [Phase 3]

View source ↗

Summary

The Diabetes Prevention Program, a Phase 3 clinical trial sponsored by NIDDK, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Non-Insulin-Dependent, Glucose Intolerance | Phase 3 | Status: COMPLETED